1. Urinary 6β-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals

   • M. M. Galteau
   • F. Shamsa

   Review Article 06 November 2003 Pages: 713 - 733

   

2. Controlled withdrawal of selective serotonin reuptake inhibitor drugs in elderly patients in nursing homes with no indication of depression

   • Johanna Ulfvarson
   • Johanna Adami
   • Christer von Bahr

   Clinical Trials 01 November 2003 Pages: 735 - 740

   

3. The effect of long-term microcrystalline chitosan therapy on plasma lipids and glucose concentrations in subjects with increased plasma total cholesterol: a randomised placebo-controlled double-blind crossover trial in healthy men and women

   • Saara Metso
   • Ritva Ylitalo
   • Terho Lehtimäki

   Clinical Trials 07 November 2003 Pages: 741 - 746

   

4. Hormonal counterregulation and consecutive glimepiride serum concentrations during severe hypoglycaemia associated with glimepiride therapy

   • A. Holstein
   • A. Plaschke
   • E.-H. Egberts

   Pharmacodynamics 22 November 2003 Pages: 747 - 754

   

5. Population pharmacokinetics of gentamicin in South African newborns

   • J. H. Botha
   • M. J. du Preez
   • M. Adhikari

   Pharmacokinetics and Disposition 18 October 2003 Pages: 755 - 759

   

6. Effect of the novel anxiolytic drug deramciclane on the pharmacokinetics and pharmacodynamics of the CYP3A4 probe drug buspirone

   • Kari Laine
   • Outi Ahokoski
   • Juha Rouru

   Pharmacokinetics and Disposition 18 October 2003 Pages: 761 - 766

   

7. Evaluation of the safety of bupropion (Zyban) for smoking cessation from experience gained in general practice use in England in 2000

   • Andrew Boshier
   • Lynda V. Wilton
   • Saad A. W. Shakir

   Pharmacoepidemiology and Prescription 13 November 2003 Pages: 767 - 773

8. Comparison of chlorzoxazone one-sample methods to estimate CYP2E1 activity in humans

   • Iza Kramer
   • Kim Dalhoff
   • Henrik E. Poulsen

   Short Communication 11 November 2003 Pages: 775 - 778

   

9. A case of rhabdomyolysis with fatal outcome after a treatment with levofloxacin

   • Fabrice Petitjeans
   • Julien Nadaud
   • Bruno Pats

   Short Communication 24 October 2003 Pages: 779 - 780

10. Increase in dihydroxycarbamazepine serum levels in patients co-medicated with oxcarbazepine and lamotrigine

    • N. Guénault
    • P. Odou
    • H. Robert

    Letter to the Editors 24 October 2003 Pages: 781 - 782